Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5ZC5

uPA-NU-09F

Summary for 5ZC5
Entry DOI10.2210/pdb5zc5/pdb
DescriptorUrokinase-type plasminogen activator chain B, 3-azanyl-5-(azepan-1-yl)-N-carbamimidoyl-6-(4-fluoranyl-1-benzofuran-2-yl)pyrazine-2-carboxamide (3 entities in total)
Functional Keywordsupa, inhibitor, hydrolase
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight28853.81
Authors
Jiang, L.G.,Buckley, B.J.,Huang, M.D.,Kelso, M.J.,Ranson, M. (deposition date: 2018-02-15, release date: 2018-12-19, Last modification date: 2023-11-22)
Primary citationBuckley, B.J.,Aboelela, A.,Minaei, E.,Jiang, L.X.,Xu, Z.,Ali, U.,Fildes, K.,Cheung, C.Y.,Cook, S.M.,Johnson, D.C.,Bachovchin, D.A.,Cook, G.M.,Apte, M.,Huang, M.,Ranson, M.,Kelso, M.J.
6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer.
J. Med. Chem., 61:8299-8320, 2018
Cited by
PubMed: 30130401
DOI: 10.1021/acs.jmedchem.8b00838
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

217705

PDB entries from 2024-03-27

PDB statisticsPDBj update infoContact PDBjnumon